TY - JOUR
T1 - Oncogenomics 2005 meeting report
T2 - Dissecting cancer through genome research
AU - Feigal, Ellen G.
AU - Dracopoli, Nicholas C.
AU - Trent, Jeffrey M.
PY - 2005/10/1
Y1 - 2005/10/1
N2 - The Oncogenomics Conference was held on February 2 to 5, 2005 at the Omni San Diego Hotel, San Diego, CA. The meeting chairpersons were Dr. Jeffrey Trent (Translational Genomics Research Institute, Phoenix, AZ) and Dr. Nicholas Dracopoli (Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ). This fourth conference sponsored by the AACR brought together a diverse group of scientists working in the Gelds of genome research, cancer biology, and epidemiology, and explored how genomic research can be used most effectively to impact the clinical response to cancer. Advances in the clinical application of pharmacogenomics to predict response to oncology therapeutic modalities led to a dramatic increase in the number of presentations and posters with a clinical focus at this year's meeting. The keynote address was given by Dr. William Evans (St. Jude Children's Hospital, Memphis, TN) who discussed the pharmacogenomics of acute lymphoblastic leukemia as a cancer paradigm.
AB - The Oncogenomics Conference was held on February 2 to 5, 2005 at the Omni San Diego Hotel, San Diego, CA. The meeting chairpersons were Dr. Jeffrey Trent (Translational Genomics Research Institute, Phoenix, AZ) and Dr. Nicholas Dracopoli (Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ). This fourth conference sponsored by the AACR brought together a diverse group of scientists working in the Gelds of genome research, cancer biology, and epidemiology, and explored how genomic research can be used most effectively to impact the clinical response to cancer. Advances in the clinical application of pharmacogenomics to predict response to oncology therapeutic modalities led to a dramatic increase in the number of presentations and posters with a clinical focus at this year's meeting. The keynote address was given by Dr. William Evans (St. Jude Children's Hospital, Memphis, TN) who discussed the pharmacogenomics of acute lymphoblastic leukemia as a cancer paradigm.
UR - http://www.scopus.com/inward/record.url?scp=25444529947&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=25444529947&partnerID=8YFLogxK
U2 - 10.1158/0008-5472.CAN-05-2659
DO - 10.1158/0008-5472.CAN-05-2659
M3 - Article
C2 - 16204021
AN - SCOPUS:25444529947
VL - 65
SP - 8587
EP - 8590
JO - Cancer Research
JF - Cancer Research
SN - 0008-5472
IS - 19
ER -